Selected Tag: Lupin
Selected Tag: Lupin

Lupin, Sandoz Tie Up to Market Ranibizumab in Multiple Global Markets

BasisPoint Insight

August 12, 2025 at 10:25 AM IST


Lupin Launches Glucagon Injection Emergency Kit in US

BasisPoint Insight

August 11, 2025 at 9:12 AM IST


Lupin Gets USFDA Nod for Diabetes, Hypoglycaemia Drugs

BasisPoint Insight

July 25, 2025 at 4:27 AM IST


Lupin Gets US FDA Observations For Two Pithampur Units

BasisPoint Insight

July 21, 2025 at 8:09 AM IST


Lupin Launches Generic Atrovent Nasal Spray In US Market

BasisPoint Insight

July 7, 2025 at 10:00 AM IST


Lupin Secures USFDA Nod For Loteprednol Gel With Market Exclusivity

BasisPoint Insight

July 1, 2025 at 5:25 PM IST


Lupin Spins Off OTC Business Into Subsidiary; Kaushal Named CEO

BasisPoint Insight

July 1, 2025 at 5:11 PM IST


Lupin Launches Prucalopride Tablets In US Market

BasisPoint Insight

June 27, 2025 at 9:36 AM IST


Lupin Gets USFDA Nod To Market Prucalopride Tablets

BasisPoint Insight

June 26, 2025 at 7:13 AM IST


Lupin Inks Deal With Sino Universal To Market COPD Drug In China

BasisPoint Insight

June 17, 2025 at 9:05 AM IST


Lupin Gets USFDA Nod For Generic Seizure Drug

BasisPoint Insight

June 9, 2025 at 9:52 AM IST


Lupin Converts $44.3 Million Loan Into Equity In Oncology Arm

BasisPoint Insight

May 27, 2025 at 8:39 AM IST


Lupin Gets USFDA Nod For Rivaroxaban Tablets

BasisPoint Insight

May 16, 2025 at 8:59 AM IST


Lupin's January-March Profit More Than Doubles, Beats Estimates 

BasisPoint Insight

May 16, 2025 at 8:08 AM IST


Lupin Launches Tolvaptan In US With 180-Day Exclusivity

BasisPoint Insight

May 14, 2025 at 9:10 AM IST


Lupin Gets US FDA Nod For Nagpur Facility With Zero Observations

BasisPoint Insight

April 18, 2025 at 11:24 AM IST


US Court Rules Against Lupin In Mirabegron Patent Case

BasisPoint Insight

April 18, 2025 at 10:01 AM IST